Holen Sie sich die Stockscreener-App
2.41
18.31%
-0.54
Handel nachbörslich:
2.46
0.05
+2.07%
Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
26.30%
3.669
|
4.978 | 3.94 | 3.963 | 2.815 |
| Operating Income/Loss |
38.94%
-12.53
|
-20.52 | -12.35 | -9.616 | -9.662 |
| Income/Loss From Continuing Operations Before Tax |
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
| Income/Loss From Continuing Operations After Tax |
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
Net Income/Loss
|
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
35.48%
-0.20
|
-0.31 | -0.19 | -0.14 | -0.14 |
| Diluted Earnings Per Share |
35.48%
-0.20
|
-0.31 | -0.19 | -0.14 | -0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):